Programmed Death Ligand 1 (PD-L1) Expression in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
D'Arcangelo, M. [1 ]
Puccetti, M. [2 ]
Bravaccini, S. [3 ]
D'Incecco, A. [4 ]
Ligorio, C. [5 ]
Terracciano, L. [6 ]
Damiani, S. [5 ]
Ravaioli, S. [3 ]
Tumedei, M. M. [3 ]
Bennati, C. [1 ]
Minuti, G. [1 ]
Vecchiarelli, S. [1 ]
Landi, L. [1 ]
Incarbone, M. [7 ]
Milesi, M. [7 ]
Cappuzzo, F. [1 ]
机构：
[1] Ausl Romagna, Oncol Hematol, Ravenna, Italy
[2] Ausl Romagna, Pathol, Ravenna, Italy
[3] IRST, Lab Biosci, Meldola, Italy
[4] Univ Hosp Siena, Ctr Immunooncol, Siena, Italy
[5] Univ Bologna, Bologna, Italy
[6] Univ Hosp Basel, Basel, Switzerland
[7] Multimedica, Milan, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
NSCLC; Tumor grade; PD-L1;
D O I：
10.1016/j.jtho.2017.09.1937
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PUB074
引用
收藏
页码：S2390 / S2390
页数：1
相关论文
共 50 条
  • [31] The Level of Programmed Cell Death Ligand 1 (PD-L1) Could Predict Survival of Patients with Resectable Small Cell Lung Cancer
    Jing, W.
    Zhu, H.
    Yu, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2366 - S2366
  • [32] Programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer (NSCLC) and correlation with clinical variables and other oncogenic drivers: An immunohistochemical analysis
    Singh, V.
    Jain, D.
    Malik, P. S.
    Kumar, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : S14 - S15
  • [33] Severe Psoriasis Flare After Anti-Programmed Death Ligand 1 (PD-L1) Therapy for Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Chia, Puey Ling
    John, Thomas
    JOURNAL OF IMMUNOTHERAPY, 2016, 39 (05) : 202 - 204
  • [34] Clinical significance of programmed death ligand-1 expression in non-small cell lung cancer (NSCLC)
    Velcheti, Vamsidhar
    Schalper, Kurt
    Carvajal, Daniel
    Chen, Lieping
    Sznol, Mario
    Gettinger, Scott N.
    Herbst, Roy S.
    Rimm, David
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer
    Rehman, Jamaal A.
    Han, Gang
    Carvajal-Hausdorf, Daniel E.
    Wasserman, Brad E.
    Pelekanou, Vasiliki
    Mani, Nikita L.
    McLaughlin, Joseph
    Schalper, Kurt A.
    Rimm, David L.
    MODERN PATHOLOGY, 2017, 30 (03) : 340 - 349
  • [36] A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer
    Schabath, Matthew B.
    Dalvi, Tapashi B.
    Dai, Hongyue A.
    Crim, Alan L.
    Midha, Anita
    Shire, Norah
    Gimbrone, Nicholas T.
    Walker, Jill
    Greenawalt, Danielle M.
    Lawrence, David
    Rigas, James R.
    Brody, Robert
    Potter, Danielle
    Kumar, Naveen S.
    Huntsman, Shane A.
    Gray, Jhanelle E.
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9469 - 9481
  • [37] Prevalence of programmed cell death ligand 1 (PD-L1) Expression among Tumor Samples from Iraqi Patients with Non-Small Cell Lung Cancer
    Yahya, Alaa Qasim
    Alhamadani, Zina A. Rajab
    Ahmed, Samir Z.
    Hussain, Ahmad Fawzi
    ADVANCEMENTS IN LIFE SCIENCES, 2025, 12 (01): : 114 - 119
  • [38] Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non-small Cell Lung Cancer
    Inoue, Yusuke
    Yoshimura, Katsuhiro
    Nishimoto, Koji
    Inui, Naoki
    Karayama, Masato
    Yasui, Hideki
    Hozumi, Hironao
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Fujisawa, Tomoyuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Asada, Kazuhiro
    Uto, Tomohiro
    Fujii, Masato
    Matsui, Takashi
    Matsuura, Shun
    Hashimoto, Dai
    Toyoshima, Mikio
    Kusagaya, Hideki
    Matsuda, Hiroyuki
    Inami, Nao
    Kaida, Yusuke
    Niwa, Mitsuru
    Ito, Yasuhiro
    Sugimura, Haruhiko
    Suda, Takafumi
    JAMA NETWORK OPEN, 2020, 3 (09) : E2011818
  • [39] Inter-rater reliability of programmed death ligand 1 ( PD-L1) scoring using the VENTANA PD-L1 (SP263) assay in non-small cell lung cancer (NSCLC)
    Williams, G. H.
    Nicholson, A. G.
    Snead, D. R. J.
    Thunnissen, E.
    Lantuejoul, S.
    Cane, P.
    Kerr, K. M.
    Loddo, M.
    Scott, M.
    Scorer, P. W.
    Barker, C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [40] Programmed death ligand-1 expression in non-small cell lung cancer
    Velcheti, Vamsidhar
    Schalper, Kurt A.
    Carvajal, Daniel E.
    Anagnostou, Valsamo K.
    Syrigos, Konstantinos N.
    Sznol, Mario
    Herbst, Roy S.
    Gettinger, Scott N.
    Chen, Lieping
    Rimm, David L.
    LABORATORY INVESTIGATION, 2014, 94 (01) : 107 - 116
12345